Mr. Paul Romness leads OS Therapeutics with over 25 years of experience in the biopharmaceutical industry having served every function within major companies like Johnson & Johnson, Amgen and Boehringer Ingelheim. He has been directly involved in the launch of 9 major products in the industry covering indications for oncology, surgery, HIV, FSD, COPD, IPF, cardiovascular and diabetes. Throughout his professional career and within his community he has focused on and advocated for unmet medical need and getting treatments to patients. Mr. Romness has a B.S. in Finance from American University and a Masters of Health Policy from George Washington University Medical Center.
